---
created: 2025-04-13
updated: 2025-04-13T10:53
id: m:AmO2qDeV
specialty: onco
specialty_id: 65
tags:
  - source/ak-original-decks::step-2::zanki-step-2
  - "source/ak-step1-v11:": 
  - theme/b&b::04-biostatists/epi::02-epidemiology::06-bias
  - source/ak-step1-v11::^systems::biostats
  - "source/ak-step2-v11:": 
  - theme/b&b::05-biostatistics/epi::02-epidemiology::06-bias
  - "source/ak-step2-v11:": 
  - theme/b&b::05-biostatistics/epi::10-bias
  - "source/ak-step2-v11:": 
  - source/ome-banner
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::biostats::zanki::uw
  - "source/ak-step2-v11:": 
  - theme/subjects::epidemiology::biostats::bias
  - source/ak-step2-v11::original-decks::zanki-step-2::biostats::uw-biostats"
type: flashcard
---

# Question
What type of bias occurs when a new screening test appears to prolong the survival of patients with a poor prognosis disease (e.g. pancreatic cancer)?   **Lead-time bias**

---

# Answer
what actually happened is the disease was detected at an earlier time, but prognosis didn't change